Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 3 |
Since 2006 (last 20 years) | 3 |
Descriptor
Drug Therapy | 14 |
Ethics | 4 |
Federal Programs | 4 |
Higher Education | 4 |
Budgets | 3 |
Costs | 3 |
Drug Addiction | 3 |
Drug Education | 3 |
Elementary Secondary Education | 3 |
Federal Aid | 3 |
Federal Government | 3 |
More ▼ |
Source
Office of Management and… | 2 |
American Journal of… | 1 |
American Pharmacy | 1 |
Journal of College and… | 1 |
Journal of School Health | 1 |
Phi Delta Kappan | 1 |
US Government Accountability… | 1 |
Author
Divoky, Diane | 1 |
Gadow, Kenneth D. | 1 |
Goodwin, Gretta L. | 1 |
Hamner, Martin E. | 1 |
Kalman, Samuel H. | 1 |
Kane, Kevin M. | 1 |
Kobasic, Dena M. | 1 |
Schlegel, John F. | 1 |
Publication Type
Legal/Legislative/Regulatory… | 14 |
Journal Articles | 5 |
Reports - Descriptive | 4 |
Opinion Papers | 3 |
Numerical/Quantitative Data | 2 |
Reports - Research | 2 |
Reports - Evaluative | 1 |
Education Level
Elementary Secondary Education | 1 |
Higher Education | 1 |
Postsecondary Education | 1 |
Audience
Policymakers | 1 |
Location
Illinois | 1 |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Goodwin, Gretta L. – US Government Accountability Office, 2020
The Bureau of Prisons (BOP) is responsible for managing the care and custody of approximately 175,000 federal inmates--an estimated 20 percent of whom have been diagnosed with a substance use disorder. The Government Accountability Office (GAO) was asked to review BOP's efforts to provide drug treatment to federal inmates. This report (1)…
Descriptors: Correctional Institutions, Institutionalized Persons, Clinical Diagnosis, Substance Abuse
Office of Management and Budget, Executive Office of the President, 2018
"Budget of the United States Government, Fiscal Year 2019" contains the Budget Message of the President, information on the President's priorities, and summary tables. 2018 has seen boosted economic growth, the creation of more than two million jobs, and the addition of nearly $5 trillion in new wealth to the stock market. Unemployment…
Descriptors: Federal Government, Budgets, Expenditures, Economic Development
Office of Management and Budget, Executive Office of the President, 2019
The 2020 Budget builds off the foundation of the President's previous budgets and provides an avenue toward spending restraint. The Budget meets the President's directive on spending reductions by agency, proposing over $2.7 trillion in spending reductions--more proposed spending reductions than any previous administration in history--and closing…
Descriptors: Federal Government, Budgets, Expenditures, Public Agencies
Congress of the U.S., Washington, DC. House Committee on Energy and Commerce. – 1987
The text of three separate Congressional hearings on medical devices and drug issues is presented in this document. The first hearing considers the need for legislation to control potential abuses and illegal diversion of human growth hormone which is produced by using recombinant deoxyribonucleic acid (DNA) technology. The second hearing…
Descriptors: Costs, Drug Legislation, Drug Therapy, Drug Use

Congress of the U.S., Washington, DC. Senate Committee on Labor and Public Welfare. – 1975
Presented is the text of the Congressional hearings examining the etiology of hyperactivity and methods of treatment for hyperactive children. Sections cover witness testimony; statements; and additional information consisting of 15 reports, articles, and publications on the topic of food additives and drug therapy. Included are communications to…
Descriptors: Drug Therapy, Etiology, Exceptional Child Research, Hyperactivity
Divoky, Diane – Phi Delta Kappan, 1989
Describes the case of Casey Jesson, a hyperactive child ordered by the state of Hew Hampshire to ingest Ritalin or forego a public education. Despite adverse side effects and the perils of drug dependency, there is greater parental and educator acceptance of Ritalin than ever before. Scientologists are sparking an anti-Ritalin campaign. Includes…
Descriptors: Behavior Problems, Case Studies, Drug Therapy, Elementary Education
Congress of the U.S., Washington, DC. House Committee on Energy and Commerce. – 1987
The texts of three hearings on issues connected with AIDS (Acquired Immune Deficiency Syndrome) are recorded in this document. The first hearing concerned the availability and cost of the drug azidothymidine (AZT) for victims of the disease and considered such questions as what a fair price for AZT is, who will pay for people currently being…
Descriptors: Acquired Immune Deficiency Syndrome, Diseases, Drug Therapy, Outcomes of Treatment

Kobasic, Dena M. – Journal of College and University Law, 1988
A discussion of the testing of new drugs in campus medical facilities reviews the process of federal approval of investigational new drugs, analyzes the implications of the federally mandated institutional review board, and the issues of informed consent and the ethics of human-subject research on campus. (MSE)
Descriptors: Disclosure, Drug Therapy, Ethics, Higher Education
Congress of the U.S., Washington, DC. House Committee on Appropriations. – 1974
This volume is primarily devoted to activities administered by the Assistant Secretary for Health. These programs include the Health Services Administration; the Center for Disease Control; the Alcohol, Drug Abuse, and Mental Health Administration; and the Health Resources Administration. Programs affecting education that are discussed include…
Descriptors: Alcohol Education, Budgets, Drug Abuse, Drug Education

Gadow, Kenneth D.; Kane, Kevin M. – Journal of School Health, 1983
Results of a survey of how teachers in Illinois administer medication to trainable mentally retarded children for seizures and behavior disorders are reported. Legal implications regarding school involvement in medication administration are discussed. (PP)
Descriptors: Administrative Problems, Drug Therapy, Elementary Secondary Education, Health Needs

Hamner, Martin E.; And Others – American Journal of Pharmaceutical Education, 1981
The roles of ethics and law in contemporary pharmacy practice are investigated. Four ethico-legal issues are discussed: profile maintenance and use, patient counseling, drug product selection, and delegation of professional tasks. The drug product selection movement has forced upon pharmacists a reassessment of ethical and legal standards.…
Descriptors: Counseling, Curriculum Development, Decision Making, Drug Therapy
Congress of the U.S., Washington, DC. House Committee on Education and the Workforce. – 2000
This document contains the proceedings of a hearing held on May 16, 2000, before the U.S. House of Representatives Subcommittee on Early Childhood, Youth, and Families. The hearing addressed issues and concerns on the use of ritalin among youth with attention deficit hyperactive disorder (ADHD). Following opening remarks of the congressmen, the…
Descriptors: Attention Deficit Disorders, Clinical Diagnosis, Drug Abuse, Drug Therapy
Kalman, Samuel H.; Schlegel, John F. – American Pharmacy, 1979
New standards of practice that describe in generic terms what a pharmacist does in fulfilling the basic responsibilities of the profession are presented as part of the Continuing Competence in Pharmacy Project of the American Pharmacy Association and the American Association of Colleges of Pharmacy. The four major areas of responsibilities for…
Descriptors: Administrator Responsibility, Drug Education, Drug Therapy, Employee Responsibility
Illinois Planning Council on Developmental Disabilities, Springfield. – 1991
This set of policy statements of the Illinois Planning Council on Developmental Disabilities, adopted from 1989 through 1990, documents Council philosophies and beliefs about issues impacting persons with developmental disabilities and their families. The value standard guiding all Council policies, plans, practices, grants, and advocacy is…
Descriptors: Acquired Immune Deficiency Syndrome, Adolescents, Adults, Children